Functional Status, Morbidity and Mortality in Cemented Versus Press-Fit Hemiarthroplasty

NCT ID: NCT01114646

Last Updated: 2018-08-07

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-03-31

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hemiarthroplasty (half of a hip replacement) is the most common treatment for displaced fractures of the femoral neck in the elderly and is associated with a better functional outcome and fewer reoperations than internal fixation. Currently, the operative management of displaced femoral neck fractures favors the use of cemented implants. This technique is believed to be more stable in the immediate post-operative period, but there is limited evidence of a decreased morbidity and mortality with cemented versus press-fit stems (uncemented). In 2006, a meta-analysis concluded that the evidence was too limited to recommend a cemented or press-fit hemiarthroplasty.

In this investigation, the morbidity, mortality and functional outcome associated with cemented and press-fit hemiarthroplasty will be compared prospectively. We propose that the use of press-fit hemiarthroplasty in the treatment of displaced subcapital fractures of the femoral neck would be associated with a decreased risk of adverse peri-operative outcomes, and that the functional results of cemented and press-fit hemiarthroplasty will be equivalent at one year.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoral Neck Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cemented Hip Hemiarthroplasty

This arm received a hemiarthroplasty with a cemented femoral prosthesis (VerSys LD/Fx, Zimmer, Warsaw, IN).

Group Type OTHER

Cemented Hip Hemiarthroplasty

Intervention Type DEVICE

The cemented femoral prosthesis is a VerSys LD/Fx, Zimmer, Warsaw, IN.

Press-Fit Hip Hemiarthroplasty

This arm received a press-fit hemiarthroplasty (VerSys Beaded FullCoat, Zimmer, Warsaw, IN),

Group Type EXPERIMENTAL

VerSys Beaded FullCoat, Zimmer

Intervention Type DEVICE

The press-fit component is a VerSys Beaded FullCoat, Zimmer, Warsaw, IN,

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cemented Hip Hemiarthroplasty

The cemented femoral prosthesis is a VerSys LD/Fx, Zimmer, Warsaw, IN.

Intervention Type DEVICE

VerSys Beaded FullCoat, Zimmer

The press-fit component is a VerSys Beaded FullCoat, Zimmer, Warsaw, IN,

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* older than 55 years
* non-pathologic, displaced subcapital femoral neck fracture
* designated for surgical reconstruction with a hemiarthroplasty by the attending surgeon
* able to ambulate ten feet prior to presentation

Exclusion Criteria

* unable to walk ten feet prior to hip fracture
* multiple extremity trauma
* pathologic fracture of the hip (including malignancy)
* clinically recognized acute myocardial infarction within thirty days prior to enrollment
* previously participated in the trial
* symptoms associated with anemia
* pre-existing metabolic bone disease
Minimum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role collaborator

Hartford Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joseph P. DeAngelis, MD

Role: STUDY_DIRECTOR

Hartford Hospital

Courtland G. Lewis, MD

Role: PRINCIPAL_INVESTIGATOR

Hartford Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hartford Hospital

Hartford, Connecticut, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

124013

Identifier Type: OTHER

Identifier Source: secondary_id

03001334HU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

POLARSTEM Cementless Hip Stem
NCT02648152 COMPLETED